NEW

VA Selects Philips to Create World’s Largest Tele-Critical Care System

Royal Philips has announced that the U.S. Department of Veterans Affairs (VA) has awarded a contract to Philips to expand VA’s tele-critical care program, creating the world’s largest system to provide veterans remote access to intensive care expertise, regardless of...

BD Launches First and Only Fully Sterile Povidone-Iodine and Isopropyl Alcohol Skin Preparation

BD (Becton, Dickinson and Company) has announced the availability of BD PurPrep patient preoperative skin preparation with sterile solution, the first and only fully sterile povidone-iodine plus isopropyl alcohol single-use antiseptic skin preparation (PVP-I; 0.83%...

PDI Receives Promising Testing Results of Super Sani-Cloth Wipes Against SARS-COV-2

PDI has generated data showing its Super Sani-Cloth wipes are effective against SARS-CoV-2, the virus that causes COVID-19. This is one of several of the company's hospital-grade disinfecting products being tested for efficacy against SARS-CoV-2 for submission to the...

New Dräger Solution Aims to Improve Long-Term Acute Care Outcomes

Dräger has leveraged its 100+ years of critical care expertise to develop a new solution designed specifically to address the needs of the long-term acute care (LTAC) environment. With Dräger’s solution, LTAC facilities can maintain quality throughout the continuum of...

Advanced Cooling Therapy Expands Team

Medical device firm Advanced Cooling Therapy (ACT) has expanded its team and achieved several strategic milestones in the commercial launch of its first product, the Esophageal Cooling Device (ECD).

Within less than 90 days of obtaining its de novo clearance from the FDA and manufacturing labeled product, the company has already had its first U.S. sales of the ECD, along with first human use in the country. A total of four clinical papers have now been published globally on the efficacy of the device.

To support the strong demand for the ECD, the company promoted Robin Drassler to Vice President of North American Sales, hired Maria Gray MA, RN, as Director for Clinical Services and added key sales managers to accommodate growth in the U.S. and globally.

The ECD is a temperature modulation device that is approved to use the esophageal environment for whole-body temperature modulation, including both cooling and warming. It’s designed to modulate and control patient temperature when clinically indicated through a single use, fully enclosed triple lumen system that is inserted into the esophagus. It received FDA de novo clearance in June of 2015, its CE Mark in Europe in 2014, and is licensed for sale in Canada and Australia. •

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X